uMedical
Medicines
Substances
Companies
Statistics
Menu
All medicines
Lokelma
Authorised
Human
Details
EMA number
EMEA/H/C/004029
ATC code
V03AE10
Authorisation
22 March 2018
Revision
12
EMA page
Therapeutic indication
Lokelma is indicated for the treatment of hyperkalaemia in adult patients.
MeSH:
Hyperkalemia
Group:
All other therapeutic products
Active substances
sodium zirconium cyclosilicate
Marketing Authorisation Holder
AstraZeneca AB
MAH
Timeline
Filter by authority:
EMA
Lokelma authorised
22 Mar 2018
authorised
regulatory
Lokelma | uMedical